Actuate Therapeutics Inc (ACTU)
R&D Expenses
$2.07M
Quarterly · Period ending: · USD
ACTU R&D Expenses
Latest reported$2.07Mperiod ending
Latest reported$2.07Mperiod ending
ACTU Quarterly R&D Expenses ($4.52M → $2.07M)
Quarterly R&D Expenses
High-resolution chart · PNG
ACTU r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 2,066,825 | |
| 2,565,244 | |
| 2,129,574 | |
| 2,177,922 | |
| 2,764,805 | |
| 3,220,319 | |
| 3,685,939 | |
| 3,757,102 | |
| 4,372,805 | |
| 6,860,430 | |
| 6,645,827 | |
| 5,761,506 | |
| 4,777,242 | |
| 4,523,757 |